Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

For decades, lab-made antibodies have been used to support patients fighting specific diseases. These treatments have become ...

In diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that damage brain ...

The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

Fresh off winning a Nobel Prize last year, and previously tackling antibodies and peptides, the University of Washington’s ...

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell. The work, ...

Antibody drugs have reshaped how we treat diseases. By harnessing the immune system to destroy tumours or temper excessive inflammation in autoimmune disorders, these therapeutics have become ...

Monoclonal antibodies, or mAbs ... a breakthrough that allowed scientists to investigate the structure and stability of complex proteins like NISTmAb in unprecedented detail.

A new study shows how an anticancer drug triggers an “outside in” signal that gets it sucked into a cancer cell.

A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.

Scientists at Stanford are developing a painless, topical vaccine using a common skin bacterium to trigger immunity.